Table 1. Basic information and treatment of patients.
No. | Age/sex/eye | Systemic medical history | IOP (mm Hg) | Initial BCVA | Final BCVA | Stage | Retinal condition |
CMT | Laser treatment | Anti-VEGF | ||||
Clock bits | The lesion involved in the macula | Hemorrhage | Hyper-reflective scar | ERM | ||||||||||
1 | 24/M/OD | Hypertension | 17.9 | 5 | 5 | 2A | 2 | N | N | N | P | 636 | P | P |
2 | 72/F/OS | Hypertension | 13.5 | 5 | 5 | 3A | 10 | N | P | N | P | 392 | P | P |
3 | 58/F/OD | Hypertension | 15.5 | 4 | 4.2 | 2B | 6 | P | N | P | P | 782 | P | P |
4 | 64/M/OS | Hypertension | 17 | 4.2 | 4.8 | 2A | 9 | N | P | N | P | 513 | P | P |
5 | 56/M/OD | Hypertension | 14.2 | 4.2 | 5 | 2B | 7 | N | N | N | N | 291 | P | P |
6 | 70/M/OS | Hypertension | 20.6 | 2 | 4 | 2B | 12 | P | N | P | P | 964 | P | P |
7 | 60/F/OS | Hypertension | 14 | 2 | 2 | 2B | 12 | P | P | N | N | 129 | P | N |
8 | 66/F/OS | Hypertension | 16 | 5 | 5 | 2A | 7 | N | N | N | N | 185 | P | P |
9 | 48/M/OD | None | 17.8 | 5 | 5 | 2B | 12 | P | P | N | N | 385 | P | N |
10 | 48/M/OS | Hypertension | 15.3 | 2 | 2 | 2B | 12 | P | P | P | P | 761 | P | N |
11 | 66/M/OS | Hypertension | 17.2 | 4 | 4 | 2B | 6 | P | N | N | N | 482 | P | P |
12 | 41/M/OD | None | 19 | 4.6 | 4.8 | 2B | 12 | P | N | N | N | 353 | N | P |
13 | 59/M/OD | Hypertension | 14.5 | 4.8 | 4.3 | 2B | 2 | P | N | P | P | 434 | N | N |
14 | 63/M/OS | Hypertension | 20 | 4.8 | 4.6 | 2B | 1 | P | N | P | P | 484 | N | P |
15 | 65/F/OD | Hypertension | 16.2 | 4 | 4 | 2B | 2 | P | N | P | N | 304 | P | P |
OD: Right eye; OS: Left eye; N: Negative; P: Positive; CMT: Central macular thickness; IOP: Intraocular pressure; VEGF: Vascular endothelial growth factor; BCVA: Best corrected visual acuity; ERM: Epiretinal membrane.